Evidence map›Paper›PMID 36966261›Full record

ArticleLeukemia2023

Impact of FLT3-ITD location on cytarabine sensitivity in AML: a network-based approach.

Giusj Monia Pugliese, Veronica Venafra, Valeria Bica, Giorgia Massacci, Sara Latini, Simone Graziosi, Thomas Fischer, Dimitrios Mougiakakos, Martin Boettcher, Livia Perfetto and 1 more

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Giusj Monia Pugliese *Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy.
Veronica Venafra *Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy.ORCID 0000-0003-3830-618X
Valeria Bica *Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy.ORCID 0000-0003-3366-5562
Giorgia MassacciDepartment of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy.ORCID 0000-0003-3223-6547
Sara LatiniDepartment of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy.ORCID 0000-0002-2353-3155
Simone GraziosiDepartment of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy.ORCID 0000-0002-6871-0354
Thomas FischerInstitute of Molecular and Clinical Immunology, University of Magdeburg, Magdeburg, Germany.
Dimitrios MougiakakosHealth Campus for Inflammation, Immunity and Infection (GCI3), University of Magdeburg, Magdeburg, Germany.ORCID 0000-0002-2817-6660
Martin BoettcherHealth Campus for Inflammation, Immunity and Infection (GCI3), University of Magdeburg, Magdeburg, Germany.ORCID 0000-0003-2911-8830
Livia PerfettoDepartment of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy.
Francesca SaccoDepartment of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy. francesca.sacco@uniroma2.it.ORCID 0000-0001-5586-9529
University of Rome Tor Vergata · ITUniversity Hospital Magdeburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CytarabineLeukemia, Myeloid, AcuteCell Line, Tumorfms-Like Tyrosine Kinase 3HumansMutationCytarabineFLT3 protein, humanfms-Like Tyrosine Kinase 3

Identifiers

PMID36966261
PMCPMC10169656
OpenAlexW4360949974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.